Jesus Alvarez-Garcia

Dec 1, 2023 | onlinelibrary.wiley.com | Sonia Garcia |Jesus Alvarez-Garcia

Invited Editorial Sacubitril/valsartan: Where mechanism meets evidence-based medicine Sonia Rivas García, Sonia Rivas García Centro de Investigación en Red en Enfermedades Cardiovasculares (CIBERCV), Department of Cardiology, Ramón y Cajal University Hospital, Madrid, Spain Search for more papers by this authorJesús Álvarez-García, Corresponding Author Jesús Álvarez-García Centro de Investigación en Red en Enfermedades Cardiovasculares (CIBERCV), Department of Cardiology, Ramón y Cajal...

Aug 27, 2023 | cfrjournal.com | Harriette Van Spall |Holger Thiele |Jesus Alvarez-Garcia |Robert J. Mentz

ESC 23 - Late-Breaker host, Harriette Van Spall (McMaster University, CA) is joined by Holger Thiele (Heart Center Leipzig at University of Leipzig, DE) to discuss the findings from the ECLS-SHOCK Trial. The leading cause of death in hospitalised patients with acute myocardial infarction is cardiogenic shock.

Aug 27, 2023 | cfrjournal.com | Jesus Alvarez-Garcia |Robert J. Mentz |Joost Daemen

ESC 23 — Dr Jesus Alvarez-Garcia (Ramon and Cajal University Hospital, ES) considers the use of ReDS technology in patients with acute heart failure (ReDS-SAFE HF) (NCT04305717) in this short interview. The ReDS-SAFE HF study (Icahn School of Medicine at Mount Sinai) aimed to test the remote dielectric sensing (ReDS) system, a novel electromagnetic technology that can noninvasively quantify changes in lung fluid concentration.